Your session is about to expire
← Back to Search
Metformin for Insulin Resistance
Study Summary
This trial will evaluate the effect of metformin on objective measures of brain aging in a sample of 300 older adults with insulin resistance.
- Insulin Resistance
- Obesity
- Abdominal Obesity
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the most common application of Metformin?
"Metformin is frequently prescribed to patients engaging in exercise, as well as those with type 1 diabetes mellitus, diabetic ketoacidosis, and polycystic ovary syndrome."
How many participants are participating in this experiment?
"Sign-ups for this test are currently closed. It was first announced on March 15th 2019 and last modified on December 7th 2022, so the study is no longer open to new participants. Nevertheless, there are still 1092 clinical trials actively recruiting patients with insulin resistance and 172 studies that can use volunteers taking Metformin."
Are there still openings available to participate in this clinical investigation?
"Unfortunately, this medical study is not presently enrolling. It was first posted on March 15th 2019 and last changed December 7th 2022. If you are seeking other clinical trials to join, there are 1092 studies actively looking for people who have insulin resistance and 172 that require participants with Metformin experience."
Are there any adverse effects associated with Metformin usage?
"Given the Stage 2 designation, our team at Power has graded Metformin's safety as a medium-level risk with a score of two. While there is some data detailing its security, none exists to confirm efficacy."
Are there any additional research initiatives regarding Metformin?
"Currently, 172 trials related to Metformin are in progress with 43 of them being Phase 3 studies. Even though Rockville Maryland is home to the majority of these investigations, 1905 medical centres across the world are running research on this drug."
Share this study with friends
Copy Link
Messenger